Sign up United Kingdom
Proactive Investors - Run By Investors For Investors

Blockchain Worldwide readies itself for the ‘new internet’ with name change

Blockchain Worldwide has changed its name and chief executive Rodger Sargent says the switch is all about the potential for the electronic ledger technology, blockchain.
Blockchain Worldwide changed its name

A change of name and business focus does not normally occur just three months after a company lists.

But Blockchain Worldwide PLC (LON:BLOC) has done just that and chief executive Rodger Sargent says the switch is all about the potential for the electronic ledger technology, blockchain.

In short, blockchain is the most exciting opportunity that has arisen since the internet, he told Proactive Investors.

Shell specialist

Sargent is someone who in old money would have been called a shellmeister.

His modus operandi, as he calls it, is to find technology business with good management teams, raise money and reverse them into companies that have little more than a listing.

Broadband supplier Satellite Services WorldWide Group PLC (LON:SSAT) , podcast specialist Audioboom Group PLC (LON:BOOM) and streaming group Meloday VR owner EVR Holdings PLC (LON:EVRH)  are all companies floated in this way by Sargent and his team.

Stapleton Capital was latest cab off the rank when it joined the standard list of the main market last October.

Huge deal flow

Watch: Blockchain Worldwide looking to build 'proper companies on proper blockchain tech'

The original aim was to engineer a reverse takeover of a telecoms-based business, but Sargent says the change of focus and name to Blockchain Worldwide was almost Hobson’s Choice.

“There was such a huge deal flow in blockchain technology, it was too good to turn down,” he says.

Sargent believes there are very few industries or applications that blockchain does not have the capability to transform.

“One you put everything on the block you can disintermediate everyone who takes money out of the system.”

In medicine for example, patient booking, medical records, drug dispensing and so on, all can be put on the blockchain.

Estate agents, too, face major disruption as all house and survey information will be freely available on the block.

Blockchain-based stock exchanges

Sargent, though, seems especially keen to see how blockchain changes the way shares and other assets are traded.

Listing any company costs a fortune, he says, but the blockchain has the potential to eliminate that.

A number of deals are being considered, Sargent says, though nothing is imminent.

Something by the end of this calendar year is as much as he will give away, though the size of any potential deal is now much larger than the £3-4mln mentioned in last year’s prospectus.

Sargent seems happy to bide his time. The company raised £1.5mln when it floated last September and with minimal overheads there is no rush, he says.

“The end game is that there will be dozens of companies looking to use blockchain.

“Some will have the wrong management, some the wrong tech, some not enough money and some too much funding.

Biding its time

“We can sit there and hopefully pick the rights ones and consolidate the corpses.”

This will be across more than one industry and may involve more than deal, but it all essentially comes back to eliminating the middleman.

Through consolidation and roll-ups, Sargent sees scope to create the definitive blockchain stock exchange, a gaming company, a medical company or even a car dealer.

“Any information that can coded and digitised can be put on a block.”

The distributed ledger can disintermediate everyone,” he repeats.

“The internet created some of the greatest companies we’ve seen and blockchain is another similar opportunity.”

At 8p, Blockchain Worldwide is valued at £3.5mln.

Join our Crypto, Blockchain and Cannabis Telegram group here
View full BLOC profile View Profile

Blockchain Worldwide PLC Timeline

Related Articles

cannabis plant
February 01 2018
Today, the group closed the US$18mln acquisition of Citiva Medical and Citiva USA
September 28 2018
HemoGenyx said it was pleased with the opportunities that had been unlocked for its CDX antibodies during the first half

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use